1. Home
  2. CION vs BVS Comparison

CION vs BVS Comparison

Compare CION & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CION

CION Investment Corporation

HOLD

Current Price

$7.61

Market Cap

344.9M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$10.49

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CION
BVS
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.9M
617.1M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
CION
BVS
Price
$7.61
$10.49
Analyst Decision
Sell
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$14.00
AVG Volume (30 Days)
604.3K
440.5K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
15.79%
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.33
Revenue
N/A
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
N/A
$7.06
P/E Ratio
$17.55
$32.03
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$5.81
52 Week High
$10.93
$10.58

Technical Indicators

Market Signals
Indicator
CION
BVS
Relative Strength Index (RSI) 59.84 75.21
Support Level $6.55 $8.43
Resistance Level $10.21 N/A
Average True Range (ATR) 0.25 0.37
MACD 0.13 0.11
Stochastic Oscillator 98.04 99.74

Price Performance

Historical Comparison
CION
BVS

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Companies portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: